| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 03/28/2002 | US20020038027 Intermediates for making HIV-protease inhibitors and methods for making HIV-protease inhibitors |
| 03/28/2002 | US20020038025 For therapy and prophylaxis of hypercholesterolemia, hyperlipemia, arteriosclerosis, vascular diseases, mycoses, parasite infections, gallstones, tumors and/or hyperproliferative disorders, diabetes |
| 03/28/2002 | US20020037856 Novel compounds possessing antibacterial, antifungal or antitumor activity |
| 03/28/2002 | CA2423262A1 Resorcinol derivatives |
| 03/28/2002 | CA2423106A1 Compounds and methods for modulation of estrogen receptors |
| 03/28/2002 | CA2422820A1 Use of statins (hmg-coa reductase inhibitors) for the preparation of medicament as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent |
| 03/28/2002 | CA2416136A1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases |
| 03/27/2002 | EP1191611A2 Piezoelectric element and process for production thereof |
| 03/27/2002 | EP1191526A2 Optical recording media |
| 03/27/2002 | EP1191020A2 Material for organic electroluminescence device and use thereof |
| 03/27/2002 | EP1189902A1 7-oxo-2-azabicyclo[2.2.1]heptanes as selective muscarinic receptor antagonist |
| 03/27/2002 | EP1189885A1 Process for the synthesis of a-nor-seco compounds with sterane skeleton |
| 03/27/2002 | EP1189879A1 INHIBITORS OF FACTOR Xa |
| 03/27/2002 | EP1189613A1 Method for the treatment of neurological or neuropsychiatric disorders |
| 03/27/2002 | EP1189612A1 Vla-4 inhibitor compounds |
| 03/27/2002 | EP1189583A1 Indole derivatives |
| 03/27/2002 | EP0865421B1 Arylethanolamine derivatives and their use as agonists of atypical beta-adrenoceptors |
| 03/27/2002 | EP0782574B1 Bicyclic carboxamides as 5-ht1a receptors ligands |
| 03/27/2002 | CN1342161A Tricyclic inhibitors of poly(ADP-ribose) polymerases |
| 03/27/2002 | CN1342152A N-substituted imide derivatives with serotonergic activity |
| 03/27/2002 | CN1342146A Substituted 1-oxo-and 1,3-dioxoisoindolines and their use in pharmaceutical compositions for reducing inflammatory cytokine levels |
| 03/27/2002 | CN1342144A N-substituted benzoyl indoles as estrogenic agents |
| 03/27/2002 | CN1342143A N-substituted indolines as estrogenic agents |
| 03/27/2002 | CN1342137A N2 phenylamidine derivatives |
| 03/27/2002 | CN1081625C 1-aryl-2-acylamino-ethane compounds and their use as meurokinin especially neurokinin 1 antagonists |
| 03/27/2002 | CA2321348A1 Aromatic derivatives with hiv integrase inhibitory properties |
| 03/26/2002 | US6362373 Chiral amino alcohols and process for preparation of same |
| 03/26/2002 | US6362371 β2- adrenergic receptor agonists |
| 03/26/2002 | US6362338 Phthalimido arylpiperazines useful in the treatment of benign prostatic hyperplasia |
| 03/26/2002 | US6362334 Phthalamide compounds |
| 03/26/2002 | US6362231 Calcium receptor active compounds |
| 03/26/2002 | US6362229 Inhibitors of multidrug transporters |
| 03/26/2002 | US6362216 Antiinflammatory agents |
| 03/26/2002 | US6362214 Thermodynamically stable form of (R)-3-[[(4-fluorophenyl) sulphonyl]amino]-1,2,3,4-tetrahydro-9H-carbazole-9-propanoic acid (ramatroban) |
| 03/26/2002 | US6362177 Cyclic amine derivatives and their use as drugs |
| 03/26/2002 | US6361999 Auxinic analogues of indole-3- acetic acid |
| 03/26/2002 | US6361594 One-step process using crystal growth inhibitors during synthesis; no size reduction needed; high dispersability, tinctorial strength, purity, and migration, heat, light and weathering fastness |
| 03/26/2002 | CA2222358C Dye precursor from plants of the genus medicago, its preparation and its application in obtaining dyes |
| 03/26/2002 | CA2119360C Fine dispersion of melanic pigments, their preparation and their use in cosmetics |
| 03/26/2002 | CA2032498C Novel 8-substituted-2-aminotetralines |
| 03/21/2002 | WO2002022694A1 Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors |
| 03/21/2002 | WO2002022577A2 Hydroxamate derivatives useful as deacetylase inhibitors |
| 03/21/2002 | WO2002022576A2 3-substituted indole carbohydrazides useful as cell proliferation and angiogenesis inhibitors |
| 03/21/2002 | WO2002022559A2 2-amino-2-alkyl-4 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 03/21/2002 | WO2002022550A2 Chiral amino alcohols and process for preparation of same |
| 03/21/2002 | WO2002008186A3 Cyclopentanoindoles, compositions containing such compounds and methods of treatment |
| 03/21/2002 | WO2001092187A8 Method for formulating organic compounds |
| 03/21/2002 | WO2001081567A3 Method for producing genomic libraries and genomic libraries produced therewith |
| 03/21/2002 | WO2001074813A3 METHOD FOR USING 2- OR 3-ARYL SUBSTITUTED IMIDAZO[1,2-a] PYRIDINES AS H3 ANTAGONISTS |
| 03/21/2002 | WO2001055106A3 Novel melanocortin receptor agonists and antagonists |
| 03/21/2002 | US20020035285 Hydrogenation catalyst |
| 03/21/2002 | US20020035137 Amino (oxo) acetic acid protein tyrosine phosphatase inhibitors |
| 03/21/2002 | US20020035136 Amino(oxo) acetic acid protein tyrosine phosphatase inhibitors |
| 03/21/2002 | US20020035127 Phenylalanine derivatives |
| 03/21/2002 | US20020035114 Substituted dimeric compounds |
| 03/21/2002 | US20020035112 Antipsychotic indolyl derivatives |
| 03/21/2002 | US20020035104 Integrin receptor inhibitors |
| 03/21/2002 | US20020035099 That are antagonists of the progesterone receptor, in a female contraceptive kit |
| 03/21/2002 | US20020034761 Methods of labelling polynucleotides with dibenzorhodamine dyes |
| 03/21/2002 | US20020034656 Organometallic complexes as phosphorescent emitters in organic LEDs |
| 03/21/2002 | US20020034605 Recording layer uses an organic dye that has an absorption maximum at a wavelength longer than that of the writing light; records information by irradiating the recording layer with writing light to act on the dye to form a pit |
| 03/21/2002 | US20020032937 Novel cationic 4-hydroxyindoles, their use for the oxidation dyeing of keratinous fibers, dyeing compositions, and methods of dyeing |
| 03/21/2002 | DE10044905A1 (2-Azabicyclo[2.2.1]hept-7-yl)methanol-Derivate als nikontinische Acetylcholinrezeptor Agonisten (2-azabicyclo [2.2.1] hept-7-yl) methanol derivatives as nikontinische acetylcholine receptor agonists |
| 03/21/2002 | CA2421054A1 Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors |
| 03/21/2002 | CA2420007A1 2-amino-2-alkyl-4 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 03/21/2002 | CA2357467A1 Methods for treating osteoarthritis using an estrogen agonist/antagonist |
| 03/20/2002 | EP1188747A1 Phenoxypropylamine compounds |
| 03/20/2002 | EP1188439A2 Cell differentiation induction with mevalonate and mevalonolactone derivatives |
| 03/20/2002 | EP1187806A2 Spermine:peptide-based surfactant compounds |
| 03/20/2002 | EP1187608A1 Indole compounds |
| 03/20/2002 | EP1187607A1 Indole compounds |
| 03/20/2002 | EP0944590B1 Aminoguanidines and alkoxyguanidines as protease inhibitors |
| 03/20/2002 | CN1341103A Pyridazin-3-one derivatives and medicines containing the same |
| 03/20/2002 | CN1341098A W-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| 03/20/2002 | CN1341078A Synthetic porous crystalline MCM-68, its synthesis and use |
| 03/20/2002 | CN1081180C Process for preparing anthracene phenanthrene and karbazole |
| 03/19/2002 | US6359151 Use as pesticides. |
| 03/19/2002 | US6359147 Reactions catalyzed by chromium (III) carboxylates |
| 03/19/2002 | US6359146 Resolution of enantiomorph mixture |
| 03/19/2002 | US6359137 Antibiotic |
| 03/19/2002 | US6358994 2-acylaminopropanamines as tachykinin receptor antagonists |
| 03/19/2002 | US6358993 Pharmaceutically active nitrogen ring compounds and methods of use thereof |
| 03/19/2002 | US6358990 Method for treating Alzheimer's disease |
| 03/19/2002 | US6358945 Compounds useful as anti-inflammatory agents |
| 03/19/2002 | US6358887 2-Phenyl-substituted heterocyclic 1,3-ketonols as herbicides and pesticides |
| 03/19/2002 | US6358504 Compounds and compositions for delivering active agents |
| 03/19/2002 | US6358496 Protecting ultraviolet-sensitive organic materials against the damaging action of uv radiation by applying indoline compound |
| 03/19/2002 | CA2079548C Carbamate derivatives of 4-amino-3- isoxazolidinones, 3-amino-1- hydroxypyrrolidin-2-ones and 1-amino-1- cyclopropanecarboxylic acid analogs, a process for their preparation and their use as medicaments |
| 03/14/2002 | WO2002020694A1 Low molecular chromophore compounds and electroluminescence display device comprising the same |
| 03/14/2002 | WO2002020526A2 Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents |
| 03/14/2002 | WO2002020513A1 Oxindole derivatives |
| 03/14/2002 | WO2002020500A2 Materials and methods to potentiate cancer treatment |
| 03/14/2002 | WO2002020480A1 Substituted fused pyrroleimines and pyrazoleimines |
| 03/14/2002 | WO2002020479A1 Substituted oxindole derivatives as tyrosine kinase inhibitors |
| 03/14/2002 | WO2002020478A1 N-benzylindole-3-acetic acid derivatives for use in the treatment of drug resistan cancer |
| 03/14/2002 | WO2002020463A2 Fxr modulators |
| 03/14/2002 | WO2002020437A2 Basic compounds containing tertiary amides with activity on tachykinin receptors, and pharmaceutical compositions containing them |
| 03/14/2002 | WO2001082909A3 2-acyl indol derivatives and their use as anti-tumour agents |
| 03/14/2002 | WO2001064668A3 1,3-dihydro-2h-indol-2-one, and their use as v1b or both v1b and v1a arginine-vasopressin ligand receptors |
| 03/14/2002 | WO2001058852A3 (r)-2-aryl-propionamides, useful in the inhibition of il-8-induced chemiotaxis of neutrophils |